High incidence of diabetes, increasing geriatric population & continuous technological advancements across the globe are the key factors contributing to high CAGR of Continuous Glucose Monitoring devices market during forecast period.
New York City, United States – June 19, 2020 /MarketersMedia/ —
According to a report by Reports and Data, the Continuous Glucose Monitoring devices market was valued at USD 3.45 Billion in 2019 and is estimated to reach USD 14.7 billion by 2026, growing at a CAGR of 19.2%. Estimating and identifying appropriate blood glucose level in patients through continuous glucose monitoring (CGM) devices is a vital component of therapy success. Continuous glucose monitoring evolved from enzyme-based electrochemical glucose sensors. It is an instrument with a small sensor attached with a transmitter for daily diabetes management.
This is the latest report covering the current COVID-19 scenario. The coronavirus pandemic has greatly affected every aspect of the worldwide industry. It has brought along various changes in market conditions. The rapidly changing market scenario and initial and future assessment of the impact are covered in the research report. The report discusses all the major aspects of the market with expert opinions on the current status along with historical data.
Get a sample PDF copy of the report @ https://www.reportsanddata.com/sample-enquiry-form/2172
Key players mentioned in the research report are:
Dexcom, Abbott Laboratories, Pfizer Inc., Inc. Baxter International, Menarini Diagnostics, Johnson & Johnson, Medtronic PLC, Animas Corporation, and Novo Nordisk A/S, ARKRAY, Inc., Bayer AG, Terumo Medical Corporation, Echo Therapeutics, Inc.; Medtronic PLC; F. Hoffmann-La Roche Ltd., GlySens Incorporated
In terms of applications, the global Continuous Glucose Monitoring Devices market can be segmented into:
Hospitals
Homecare settings
Others
In terms of Component, the global Continuous Glucose Monitoring Devices market can be segmented into:
Insulin Pumps
Transmitters & receivers
Sensors
The Continuous Glucose Monitoring Devices Market is analyzed on the basis of dynamics of demand and supply, pricing, total volume produced, revenue generated, and others. The manufacturing is studied on the basis of several factors such as manufacturing plant distribution, industry production, production capacity, and research and development. It also delivers accurate market evaluations with the use of SWOT analysis, investment analysis, returns analysis, and growth trend analysis, and others.
To get a discount on the report, click @ https://www.reportsanddata.com/discount-enquiry-form/2172
For geographical segmentation, regional supply, application-wise, and type-wise demand, key players, and others, this report covers the following regions: North America, Europe, Asia-Pacific, South America, and Middle East & Africa. The report sheds light on the competitive landscape of the market that covers the product offerings, services, market shares, and business overview. This Continuous Glucose Monitoring Devices Market research report covers various dynamic aspects like the market drivers, restraints and challenges, and growth prospects. The prominent and leading companies are profiled in the report.
Key findings from the report suggest
• Insulin Pumps segment is expected to attain the highest CAGR of 15.6% due to technological developments aiding advanced diabetes care management the region where geriatric population is growing such as China and India.
• Transmitters & Receivers has been the largest segment due to its critical importance in the devices. It is expected to maintain its market share dominance in the forecast period.
• Based on End-use, Homecare settings segment has the largest market share due to advanced technological developments in the market and ease of use of the CGM devices; that enables the healthcare providers to provide best of the services to their patients
• Several personal CGM systems are available in the United States for daily use by people with diabetes. For instance, the Abbott FreeStyle Libre flash CGM system received FDA approval in September 2017 for stand-alone use. This sensor and transmitter system requires no calibrations or fingerstick blood glucose confirmations to make diabetes treatment decisions.
Get the full report description, TOC, Table of Figures, Charts @ https://www.reportsanddata.com/report-detail/continuous-glucose-monitoring-devices-market
This research report delivers a 360 overview of the competitive landscape of the Global Continuous Glucose Monitoring Devices Market. Furthermore, it includes massive data regarding the latest trends, technological advancements, and methodologies. The study analyzes the Global Continuous Glucose Monitoring Devices Market in a detailed and extensive manner for the readers to gain better insights.
Thank you for reading our report. For further details or to inquire about customization, please let us know and we will offer you the report as per your needs.
About Us:
Our in-house experts assist our clients with advice based on their proficiency in the market that helps them in creating a compendious database for the clients. Our team offers expert insights to clients to guide them through their business ventures. We put in rigorous efforts to keep our clientele satisfied and focus on fulfilling their demands to make sure that the end-product is what they desire. We excel in diverse fields of the market and with our services extending to competitive analysis, research and development analysis, and demand estimation among others, we can help you invest your funds in the most beneficial areas for research and development.
Contact Info:
Name: John Watson
Email: Send Email
Organization: Reports And Data
Address: 40 Wall St. 28th floor New York City, NY 10005 United States
Phone: +1-212-710-1370
Website: https://www.reportsanddata.com/
Source: MarketersMedia
Release ID: 88964539
